These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20272797)

  • 1. Combined system disease and hematologic relapse occurring in persons with pernicious anemia treated with synthetic folic acid (pteroyl glutamic acid) for a period of two years.
    VILTER RW; VILTER CF; HAWKINS V
    Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():35. PubMed ID: 20272797
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pernicious anemia with pteroyl glutamic acid (folic acid).
    SCHWARTZ SO; ARMSTRONG BE
    Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():36. PubMed ID: 20272798
    [No Abstract]   [Full Text] [Related]  

  • 3. The development and progression of subacute combined degeneration of the spinal cord in patients with pernicious anemia treated with synthetic pteroylglutamic (folic) acid.
    ROSS JF; BELDING H; PAEGEL BL
    Blood; 1948 Jan; 3(1):68-90. PubMed ID: 18920892
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of Excess Acetylcholine in the Serum of Pernicious Anemia Patients by Treatment With Pteroyl Glutamic Acid, Liver Extract, or Ventriculin.
    Davis JE
    Science; 1946 Dec; 104(2712):605-6. PubMed ID: 17749270
    [No Abstract]   [Full Text] [Related]  

  • 5. The occurrence of combined system disease in persons with pernicious anemia during treatment with the Lactobacillus casei factor (folic acid).
    VILTER CF; VILTER RW; SPIES TD
    J Lab Clin Med; 1947 Mar; 32(3):335. PubMed ID: 20289821
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of pernicious and related anemias with synthetic folic acid; observations on the maintenance of a normal hematologic status and on the occurrence of combined system disease at the end of one year.
    VILTER CF; VILTER RW; SPIES TD
    J Lab Clin Med; 1947 Mar; 32(3):262-73. PubMed ID: 20289795
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of 4-amino pteroyl glutamic acid (aminopterin) in vitro on a culture of bone marrow of pernicious anemia].
    FRANCO J; ARKUN SN
    Sang; 1951; 22(5):413-25. PubMed ID: 14865894
    [No Abstract]   [Full Text] [Related]  

  • 8. The occurrence of combined system disease in persons with pernicious anemia during treatment with the L. casei factor (folic acid).
    VILTER CF; VILTER RW; SPIES TD
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():26. PubMed ID: 20248531
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the utilization of pteroyl hexaglutamyl glutamic acid (vitamin Bc conjugate) in pernicious anemia.
    BETHELL FH; SWENDSEID ME
    J Lab Clin Med; 1947 Mar; 32(3):337-40. PubMed ID: 20289823
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of pteroylglutamic acid administration on the serum vitamin B12 concentration in pernicious anemia in relapse.
    BOK J; FABER JG; DE VRIES JA; KROESE WF; NIEWEG HO
    J Lab Clin Med; 1958 May; 51(5):667-71. PubMed ID: 13539482
    [No Abstract]   [Full Text] [Related]  

  • 11. Relapse of patients with pernicious anemia receiving folic acid.
    HANSEN-PRUSS OC
    Am J Med Sci; 1947 Nov; 214(5):465-8. PubMed ID: 20271015
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver extract, folic acid, and thymine in pernicious anaemia and subacute combined degeneration.
    SPIES TD; STONE RE
    Lancet; 1947 Feb; 1(6440):174-6. PubMed ID: 20284022
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on the utilization of pteroyl hexaglutamyl glutamic acid (vitamin Bc conjugate) in pernicious anemia.
    BETHELL FH; SWENDSEID ME
    Proc Annu Meet Cent Soc Clin Res U S; 1946 Nov 1-2; 19():28. PubMed ID: 20248533
    [No Abstract]   [Full Text] [Related]  

  • 14. Folic acid (pteroylglutamic acid) studies; hematologic remissions in pernicious anemia.
    KRACKE RR; RISER WH
    Proc Soc Exp Biol Med; 1947 Feb; 64(2):179-81. PubMed ID: 20287371
    [No Abstract]   [Full Text] [Related]  

  • 15. Folic acid in pernicious anemia; failure to prevent neurologic relapse.
    HEINLE RW; WELCH AD
    J Am Med Assoc; 1947 Mar; 133(11):739-41. PubMed ID: 20283982
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapse of pernicious anaemia during maintenance therapy with folic acid.
    MOLLIN DL
    Lancet; 1948 Dec; 2(6537):928-30. PubMed ID: 18121663
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with pterolyglutamic (synthetic folic) acid in the treatment of pernicious anemia.
    HALL BE; WATKINS CH
    J Lab Clin Med; 1947 Jun; 32(6):622-34. PubMed ID: 20242836
    [No Abstract]   [Full Text] [Related]  

  • 18. A survey of the treatment of pernicious anemia in relapse; a comparison of the hematopoietic response to liver extract and folic acid, L. casei factor; limitations of the reticulocyte response as a measure of anti-pernicious anemia potency.
    CLARK GW
    Am J Med Sci; 1948 Jul; 216(1):71-7. PubMed ID: 18877318
    [No Abstract]   [Full Text] [Related]  

  • 19. Ineffective utilization of conjugated pteroylglutamic (folic) acid in pernicious anemia.
    WELCH AD; HEINLE RW
    J Biol Chem; 1946 Aug; 164(2):787. PubMed ID: 21001175
    [No Abstract]   [Full Text] [Related]  

  • 20. The excretion of porphyrin by pernicious anemia patients treated with pteroylglutamic acid.
    STEINKAMP RC; SHUKERS CF
    Fed Proc; 1947; 6(1):295. PubMed ID: 20343614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.